相关实验视频

Updated: Jun 12, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

毒素在手术条件下的非化品使用

Line Marker, Peter Toquer¹, John Thomas Helgstrand^2,3

¹Department of Orthopaedic Surgery, Zealand University Hospital, Køge, Denmark.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society

|September 24, 2024

概括

毒素 (BTX) 是一种神经毒素,用于肌肉放松和减轻疼痛. 本综述探讨了其在外科手术中的日益广泛使用,通常证据有限或监管机构批准.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.
手术科学手术科学

背景情况:

毒素 (BTX) 是一种神经毒素,通过抑制乙胆释放来诱导可逆肌肉放松.
此外,BTX还会影响胆性自身免疫神经系统,从而有可能减少疼痛敏感性.
虽然BTX广泛用于化品手术,但BTX越来越多地被用于医疗和外科应用.

研究的目的:

审查各种外科专业的肉毒毒素 (BTX) 的应用.
为提供BTX在非整形外科条件的利用概述.
要突出BTX在外科手术中的使用趋势,通常在强有力的临床证据或监管批准 (例如,欧洲药物管理局 (EMA)) 之前.

主要方法:

这项研究是一种叙事性审查.
它综合了关于在手术环境中使用肉毒素 (BTX) 的现有文献.
该审查侧重于不同外科领域的非化品应用.

主要成果:

毒素 (BTX) 正在众多外科专业中被采用,用于各种非化品指示.
支持许多新应用的证据往往有限.
在外科手术中BTX的几种用途缺乏像EMA这样的监管机构的正式批准.

结论:

毒素 (BTX) 在外科实践中是一个不断增长的,但往往缺乏证据的治疗选择.
需要进一步的研究来确定BTX在许多非化品手术条件中的有效性和安全性.
在外科手术中扩大BTX的使用要求仔细考虑临床证据和监管状况.

关键词:

博托克斯 (Botox) 是一种肉毒毒素是一种毒素.未来的发展发展未来的发展标志表示标志表示标志表示用于治疗用途.治疗治疗治疗治疗治疗治疗

更多相关视频

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

$Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain$ 09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

相关概念视频

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...